At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 49 enrolled
Drug / intervention
Rocuronium +1 moredrug
Likely dose
Rocuronium 0.3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optimization of Surgical Conditions During Laparoscopic Cholecystectomy With Deep or Moderate Neuromuscular Blockade
In Brief
A Phase 4 clinical trial evaluating Rocuronium for Cholecystectomy, Laparoscopic. Completed, enrolled 49 participants across 1 site.
Detailed Summary
The purpose of this investigation is to compare the surgical conditions during laparoscopic cholecystectomy at a low intra-abdominal pressure with deep or moderate muscle relaxation. The primary hypothesis is that surgical conditions during laparoscopic cholecystectomy are better with deep muscle relaxation than moderate muscle relaxation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholecystectomy, Laparoscopic
CountriesDenmark
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2012
Enrollment StartMar 2012
Primary CompletionNov 2012
TodayJul 2026
First PostedFeb 1, 2012
Enrollment StartMar 1, 2012
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.4 years ago
Interventions
Rocuroniumdrug
Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h
Rocuroniumdrug
Intravenous use: 0,3 mg/kg followed by NaCl-infusion